Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10040202HBVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS10040086HBVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS30010849HIVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS20037373HPVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS20039601HPVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS44012431HTLV-1ENSG00000157404.17protein_codingKITYesNo3815P10721
TCGA Plot Options
Drug Information
GeneKIT
DrugBank IDDB04868
Drug NameNilotinib
Target IDBE0000453
UniProt IDP10721
Regulation Typeantagonist
PubMed IDs17699867
CitationsGuo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR: Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer Res. 2007 Aug 15;13(16):4874-81.
GroupsApproved; Investigational
Direct ClassificationBenzanilides
SMILESCC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
PathwaysNilotinib Inhibition of BCR-ABL
PharmGKBPA165958345
ChEMBLCHEMBL255863